Why the study?
Obesity increases cardiovascular risk, but the role of echocardiography in the early detection of subclinical cardiac abnormalities in obese patients with preserved ejection fraction undergoing bariatric surgery needed assessment.
Does bariatric surgery improve morpho-functional cardiac abnormalities in severely obese patients with preserved ejection fraction?
Cohort (n=40)
No
Does bariatric surgery improve morpho-functional cardiac abnormalities in severely obese patients with preserved ejection fraction?
Absolute Event Rate: 22% vs 60%
p-value: p=0.001
Bariatric surgery in severely obese patients is associated with significant reverse cardiac remodeling and complete resolution of subclinical systolic dysfunction at 10 months.
Echocardiography may identify subclinical abnormalities in obese patients with preserved EF pre-bariatric surgery; hypothesis-generating and should not yet change practice.
Aim: Obesity is associated with an increased cardiovascular risk. This study aimed to assess the role of echocardiography in the early detection of subclinical cardiac abnormalities in a cohort of obese patients with a preserved ejection fraction (EF) undergoing bariatric surgery. Methods and Results: Forty consecutive severely obese patients (body mass index≥35 kg/m2) referring to our center for bariatric surgery were enrolled in this prospective cohort study. Despite a baseline EF of 61% ± 3%, almost half patients (43%) had a systolic dysfunction (SD) defined as global longitudinal strain (GLS)>−18%, and most of them (60%) had left ventricular hypertrophy (LVH) or concentric remodeling (CR). At 10-months after surgery, body weight decreased from 120 ± 15 kg to 83 ± 12 kg, body mass index from 44 ± 5 kg/m² to 31 ± 5 kg/m² (both P < 0.001). Septal and left ventricular posterior wall thickness decreased respectively from 10 ± 1 mm to 9 ± 1 mm (P = 0.004) and from 10 ± 1 mm to 9 ± 1 mm (P = 0.007). All systolic parameters improved: EF from 61% ± 3% to 64% ± 3% (P = 0.002) and GLS from −17% ± 2% to −20% ± 1% (P < 0.001). Epicardial fat thickness reduction (from 4.7 ± 1 mm to 3.5 ± 0.7 mm, P < 0.001) correlated with the reduction of left atrial area (P < 0.001 R = 0.35) and volume (P = 0.02 R = 0.25). Following bariatric surgery, we observed a reduced prevalence of LVH/CR (before 60%, after 22%, P = 0.001) and a complete resolution of preclinical SD (before 43%, after 0%, P < 0.001). Moreover, a postoperative reduction of at least 30 kg correlated with regression of septal hypertrophy (P < 0.001).Conclusions: Obese patients candidate to bariatric surgery have an high prevalence of preclinical SD and LVH/CR, early detectable with echocardiography. Bariatric surgery is associated with reverse cardiac remodeling; it might also have a preventive effect on atrial fibrillation occurrence by reducing its substrate.
No takes yet. Share an insight, caveat, or question.
Scarlatta et al. (2020) conducted a cohort in Severe obesity (n=40). Bariatric surgery vs. Baseline (pre-surgery) was evaluated on Prevalence of left ventricular hypertrophy (LVH) or concentric remodeling (CR) (p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: